Dissertation
⭐ 4.3
Clinical Trials for Pharmaceutical Firms: Policy And Regulation | Post-Pandemic Lessons
Abstract
This dissertation investigates “Clinical Trials for Pharmaceutical Firms: Policy And Regulation | Post-Pandemic Lessons” using a event study methodology. Through a institutional lens, the analysis integrates multi-source data to derive a stakeholder-aligned blueprint for researchers and practitioners.